BACKGROUND Findings of prior studies have been inconclusive about the ocular effects of thiazolidinediones on diabetic macular edema (DME). We evaluated, in patients with type 2 diabetes (T2D), the short-term and long-term risks of developing DME among users vs nonusers of thiazolidinediones. METHODS A retrospective cohort study of 103,368 patients with T2D and no DME at baseline using The He...

Dimethyl ether (DME)/C1-C4 alkane mixtures are ideal fuel for homogeneous charge compression ignition (HCCI) engines. The comparison of delay and multi-stage DME/C1-C4 can provide theoretical guidance expanding the load range controlling time DME HCCI However, interaction mechanism between C1-C4 under engine relevant high-pressure low-temperature conditions remains to be revealed, especially co...

PURPOSE To assess the association of serum lipids with diabetic retinopathy (DR), diabetic macular edema (DME), and macular thickness in adults with diabetes. METHODS Diabetic patients aged ≥ 18 years were prospectively recruited from specialized eye clinics in Melbourne, Australia. Fasting total-C (cholesterol), triglyceride, HDL-C, non-HDL-C, and LDL-C were assessed. DR was graded from fund...

Due to several apparent advantages over methanol, dimethyl ether (DME) has been viewed as a promising alternative fuel for direct fuel cell technology. Similar to methanol, DME oxidation requires a surface oxidant, such as OH, for the removal of adsorbed CO. Consequently, the reaction occurs at much faster rates on binary PtRu catalysts than Pt alone. In this work, PtRu catalysts with a wide va...

Diabetic macular edema (DME) can cause blindness in diabetic patients suffering from diabetic retinopathy (DR). DM parameters controls (glycemia, arterial tension, and lipids) are the gold standard for preventing DR and DME. Although the vascular endothelial growth factor (VEGF) is known to play a role in the development of DME, the pathological processes leading to the onset of this disease ar...

BACKGROUND This study evaluated the effect of intravitreal injection of bevacizumab (IVB) on macular edema associated with diabetic retinopathy (DME) or branch retinal vein occlusion (BRVOME) using laser speckle flowgraphy. METHODS A comparative interventional study of 25 eyes from 22 patients with macular edema (DME group: 12 eyes; BRVOME group: 13 eyes) who underwent IVB. Mean blur rate (MB...

Treatment of Ca or Sr metal with Hg(C(6)F(5))(2) and 2,4,6-trimethylphenol (HOmes) in 1,2-dimethoxyethane (dme) at room temperature resulted in C-F bond activation, giving rise to the unique fluoro(aryloxo)alkaline earth cages [Ca(5)(mu(4)-F)(mu(3)-F)(4)(mu-Omes)(4)(Omes)(dme)(4)] 1 and [Sr(10)(mu(4)-F)(4)(mu(3)-F)(4)(mu-Omes)(12)(dme)(4)] 2, which can be viewed as arrested fluorite structures.

D iabetic macular edema (DME) is a treatable sequela of diabetic retinopathy and a significant cause of visual morbidity among working age individuals worldwide. While anti-vascular endothelial growth factor (anti-VEGF) agents are first-line agents in the management of DME, corticosteroids and laser therapy can play a role as well. Despite a growing understanding of best clinical practices, man...

BACKGROUND Anti vascular endothelial growth factor (VEGF) therapy is an established treatment for various retinal diseases. Long-term data on injection frequencies and visual acuity (VA), however, are still rare. METHODS Five-year analysis of real-life VA developments and injection patterns from 2072 patients (2577 eyes; 33 187 injections) with chronically active disease undergoing pro-re-nat...

Rare earth metals activated with ca. 2% iodine react directly with 2,6-diisopropylphenol (HOdip) in tetrahydrofuran (thf), 1,2-dimethoxyethane (dme), and dig-dme (dig = di(2-methoxyethyl) ether) to give solvated phenolate complexes [Ln(Odip)(3)(thf)(n)] (Ln = La, Nd, n = 3; Ln = Sm, Dy, Y, Yb, n = 2), [Eu(Odip)(μ-Odip)(thf)(2)](2), [Ln(Odip)(3)(dme)(2)] (Ln = La, Yb) and [La(Odip)(3)(dig)] in g...